Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Prof Roberto Orecchia speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the role of radiation therapy in uterine sarcomas.
He explains the different subtypes and therapy options available.
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
Management of prostate cancer in Africa: Looking to the future
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
The advantages of IORT for early breast cancer treatment